>

Correlation Between Johnson Johnson and Astrazeneca PLC

Analyzing existing cross correlation between Johnson Johnson and Astrazeneca PLC. You can compare the effects of market volatilities on Johnson Johnson and Astrazeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Astrazeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Astrazeneca PLC.

Specify exactly 2 symbols:

Refresh Compare

Diversification Opportunities for Johnson Johnson and Astrazeneca PLC

Johnson Johnson diversification synergy
0.54
<div class='circular--portrait-small' style='background:#FF6600;color: white;font-size:1.1em;padding-top: 12px;;'>JNJ</div>
<div class='circular--portrait-small' style='background:#0D8ECF;color: white;font-size:1.6em;padding-top: 6px;;'>AS</div>

Very weak diversification

The 3 months correlation between Johnson and Astrazeneca is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Astrazeneca PLC in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Astrazeneca PLC and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Astrazeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astrazeneca PLC has no effect on the direction of Johnson Johnson i.e. Johnson Johnson and Astrazeneca PLC go up and down completely randomly.

Pair Corralation between Johnson Johnson and Astrazeneca PLC

Considering 30-days investment horizon, Johnson Johnson is expected to generate 0.45 times more return on investment than Astrazeneca PLC. However, Johnson Johnson is 2.2 times less risky than Astrazeneca PLC. It trades about 0.25 of its potential returns per unit of risk. Astrazeneca PLC is currently generating about 0.04 per unit of risk. If you would invest  13,717  in Johnson Johnson on January 25, 2020 and sell it today you would earn a total of  1,276  from holding Johnson Johnson or generate 9.3% return on investment over 30 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Astrazeneca PLC

 Performance (%) 
    
  Timeline 
Johnson Johnson 
1616

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 16 (%) of all global equities and portfolios over the last 30 days. Regardless of fairly conflicting technical and fundamental indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in March 2020.
Astrazeneca PLC 
22

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Astrazeneca PLC are ranked lower than 2 (%) of all global equities and portfolios over the last 30 days. Allthough quite persistent forward indicators, Astrazeneca PLC is not utilizing all of its potentials. The existing stock price mess, may contribute to short term losses for the partners.

Johnson Johnson and Astrazeneca PLC Volatility Contrast

 Predicted Return Density 
    
  Returns 
Check out your portfolio center. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.